SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: DEER HUNTER who wrote (685)12/22/1998 11:40:00 AM
From: Henry Niman  Respond to of 1906
 
Thanks for the heads up. A very similar summary came out at 1:04 AM:

biocognizance.com



To: DEER HUNTER who wrote (685)1/1/1999 6:16:00 AM
From: Henry Niman  Respond to of 1906
 
Today's Science has a article on ARIA's transcription regulation technology which controls in vivo Epogen levels with an oral antibiotic, Rapamycin. Bloomberg's comments, after Thursday's close, are at:
biocognizance.com